SEC Form D filing
Reprise Biomedical, Inc., 2026-05-21
An SEC Form D private-offering notice from Plymouth, MN, a $10,000,000 filer-stated offering target in Biotech. Filed 2026-05-21. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Reprise Biomedical, Inc. Verified via SEC Form D
Filed 2026-05-21Filed to raise $10,000,000First money in 2026-05-14Raised so far $9,246,100HQ (as filed) Plymouth, MNSector Biotech machine-classified from the filing aloneStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 13 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- NoHo APC Inc., 2026-05-26, $20M, St. Paul, MN
- ViCardia Therapeutics, Inc., 2026-05-21, $700K, San Francisco, CA
- Invisia Space Inc, 2026-05-21, $800K, Excelsior, MN
- Conexeu Sciences Inc., 2026-05-21, $45K, Reno, NV
- Juniper Health, Inc., 2026-05-21, $800K, Minneapolis, MN
- beyondGREEN biotech Inc., 2026-05-21, Santa Ana, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.